CLINICAL RESEARCH STUDY
Healthy Volunteers
STUDY DETAILS
Clinical Research Study of an Investigational Medication in Healthy Volunteers.
San Antonio, TX
Up to $10000
Participation in this study includes 1 screening visit, 1 stay of 8 nights, 6 follow-up visits and 1 follow-up phone call.
Male/Female
Age 18 - 45
Non Smoker
APPLY NOW
Healthy Volunteers
00350730
ICON is conducting a study for healthy men and women ages 18-45. Volunteers must be available for 1 stay of 8 nights, 6 follow-up visits and 1 follow-up phone call. Qualified study participants may earn up to $10,000 for study-related participation. The study product is being tested to evaluate safety and tolerability of an investigational drug for treatment of HIV. Even if you do not qualify, you may receive up to $300 for referring a qualified participant. For more details, call ICON today at 210-225-5437.
What does the study involve?
  • 1 screening visit
  • 1 stay of 8 nights
  • 6 follow-up visits
  • 1 follow-up phone call
Who can participate?
  • Male/Female
  • Age 18 - 45
  • Non Smoker
  • BMI 19.0 - 30.0
  • Healthy
Study group calendars
Online appointment scheduling
How much can I get paid?
The amount you can get paid varies by study and time involved. If you meet the requirements to participate in the clinical trial and are selected to enroll, the payment terms (how much and how often) will be explained to you during the consenting process. Payment is also based on whether you complete all visits and procedures in the study.
What is a clinical study?
Clinical studies (also called clinical trials or clinical research) are used to determine whether new drugs or treatments are both safe and effective. Carefully conducted clinical studies are the fastest and safest way to find treatments that work – and they are only possible with the help of participants like you.
Related Studies
Get in Touch
ADDRESS
ICON 8307 Gault Lane San Antonio, TX 78209
PHONE NUMBER
(210) 225-5437 (210) 225-5437
Actual study participant
Lenexa, KS
“Enjoyed my stay and the staff are wonderful.”
Actual study participant
Lenexa, KS
“All employees were extremely courteous and helpful.”
Actual study participant
Lenexa, KS
“Wonderful staff. I am a newbie, but friendly and helpful staff eased the apprehensions.”
Actual study participant
Lenexa, KS
“ICON has an excellent staff from recruiters to medical staff, and a nice, clean facility.”
Actual study participant
Lenexa, KS
“It looks to me like ICON staff is courteous and very knowledgeable of the proceedings and well-being of every participant.”
Actual study participant
Lenexa, KS
“The staff at ICON is wonderful. Very professional and friendly.”
Actual study participant
Lenexa, KS
“Staff is friendly and professional.”
Frequently asked questions
Will I get paid for participating in a clinical study?

While participation in a clinical study is voluntary, you may be paid for your time and travel. Compensation is based on the length of the study, the number of overnight stays in our clinic and the number of out-patient visits you attend. You may also be compensated for some procedures depending upon the study. All payments we make for study participation have been approved by an Independent Review Board (IRB). The method and frequency of payment will be described in detail in the Informed Consent Form (ICF).

What if I’d like to refer a friend or family member for a study?

Even if you don’t qualify for a particular study, you may be able to refer a friend or family member. If approved by an Independent Review Board (IRB), ICON may be able to provide you a referral bonus of up to $500 for each qualified study participant that you refer. To qualify for the payment, the person you refer must:

• Be a first-time volunteer

• Mention your name when applying over the phone

• Fully participate in the study

All payments from ICON must be approved by an IRB before any payment may be made to you. Please contact us for more information.

Meet some of our extraordinary people and discover what ICON means to them!
About ICON
We’re committed to the drug development process because we understand how it impacts the lives of patients and their families. At the end of the day, we’re not just researchers. We’re patients. We’re survivors. We’re family members.